DK2289533T3 - Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider - Google Patents

Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider

Info

Publication number: DK2289533T3
Authority: DK; Denmark
Prior art keywords: peptides; carendothelial; well; growth factor; factor receptor
Prior art date: 2005-02-28

Application number

DK10177960.1T

Other languages

English (en)

Inventor

Hideaki Tahara

Takuya Tsunoda

Masabumi Shibuya

Shuichi Nakatsuru

Original Assignee

Oncotherapy Science Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-02-28

Filing date

2006-02-17

Publication date

2013-12-02

2006-02-17 Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc

2013-12-02 Application granted granted Critical

2013-12-02 Publication of DK2289533T3 publication Critical patent/DK2289533T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Cell Biology (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Vascular Medicine (AREA)

DK10177960.1T 2005-02-28 2006-02-17 Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider DK2289533T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US65752705P	2005-02-28	2005-02-28
EP06714491A EP1855707B1 (en)	2005-02-28	2006-02-17	Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides

Publications (1)

Publication Number	Publication Date
DK2289533T3 true DK2289533T3 (da)	2013-12-02

Family

ID=36581423

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK09007549.0T DK2095822T3 (da)	2005-02-28	2006-02-17	Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider
DK10177960.1T DK2289533T3 (da)	2005-02-28	2006-02-17	Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider
DK06714491.5T DK1855707T3 (da)	2005-02-28	2006-02-17	Epitoppeptider afledt af vaskulær endothelial vækstfaktorreceptor 1 samt vacciner, der indeholder disse peptider

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK09007549.0T DK2095822T3 (da)	2005-02-28	2006-02-17	Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK06714491.5T DK1855707T3 (da)	2005-02-28	2006-02-17	Epitoppeptider afledt af vaskulær endothelial vækstfaktorreceptor 1 samt vacciner, der indeholder disse peptider

Country Status (10)

Country	Link
US (4)	US7919099B2 (da)
EP (4)	EP2289533B1 (da)
JP (3)	JP4931154B2 (da)
CY (1)	CY1112867T1 (da)
DK (3)	DK2095822T3 (da)
ES (3)	ES2442294T3 (da)
PL (3)	PL1855707T3 (da)
PT (3)	PT1855707E (da)
SI (3)	SI1855707T1 (da)
WO (1)	WO2006093030A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1548032B9 (en)	2002-09-12	2009-10-28	Oncotherapy Science, Inc.	Kdr peptides and vaccines comprising the same
CA2678432A1 (en) *	2007-02-16	2008-08-21	Oncotherapy Science, Inc.	Vaccine therapy for choroidal neovascularization
TW201109029A (en) *	2009-06-11	2011-03-16	Oncotherapy Science Inc	Vaccine therapy for choroidal neovascularization
KR20140138900A (ko)	2012-03-09	2014-12-04	온코세라피 사이언스 가부시키가이샤	펩티드를 포함한 의약 조성물
US9840553B2 (en)	2014-06-28	2017-12-12	Kodiak Sciences Inc.	Dual PDGF/VEGF antagonists
KR20250057128A (ko)	2015-12-30	2025-04-28	코디악 사이언시스 인코포레이티드	항체 및 이의 접합체
JP7168228B2 (ja) *	2017-05-19	2022-11-09	慶應義塾	脳神経疾患に対するペプチドワクチン及びペプチドワクチン組成物
MX2020009152A (es)	2018-03-02	2020-11-09	Kodiak Sciences Inc	Anticuerpos de il-6 y constructos de fusion y conjugados de los mismos.
CN114786731A (zh)	2019-10-10	2022-07-22	科达制药股份有限公司	治疗眼部病症的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4722848A (en)	1982-12-08	1988-02-02	Health Research, Incorporated	Method for immunizing animals with synthetically modified vaccinia virus
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
JPH0418667A (ja) *	1989-07-05	1992-01-22	Tohoku Nippon Denki Software Kk	自動配送システム
JPH0350140A (ja) *	1989-07-18	1991-03-04	Seiko Epson Corp	分布屈折率レンズの製造方法
ATE281469T1 (de)	1993-03-25	2004-11-15	Merck & Co Inc	Inhibitor des wachstumsfaktors für gefäss- endothelzellen
US5679647A (en)	1993-08-26	1997-10-21	The Regents Of The University Of California	Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5804566A (en)	1993-08-26	1998-09-08	The Regents Of The University Of California	Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5739118A (en)	1994-04-01	1998-04-14	Apollon, Inc.	Compositions and methods for delivery of genetic material
US5736524A (en)	1994-11-14	1998-04-07	Merck & Co.,. Inc.	Polynucleotide tuberculosis vaccine
US5922687A (en)	1995-05-04	1999-07-13	Board Of Trustees Of The Leland Stanford Junior University	Intracellular delivery of nucleic acids using pressure
AU6632496A (en)	1995-08-03	1997-03-05	Rijksuniversiteit Te Leiden	Cell derived antigen presenting vesicles
US5853719A (en)	1996-04-30	1998-12-29	Duke University	Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
US6100071A (en) *	1996-05-07	2000-08-08	Genentech, Inc.	Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
JP2000516090A (ja)	1996-07-26	2000-12-05	スローン―ケッタリングインスティチュートフォーキャンサーリサーチ	遺伝子的免疫化のための方法と試薬
FR2766205B1 (fr)	1997-07-16	2002-08-30	Inst Nat Sante Rech Med	Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US6200954B1 (en) *	1998-09-04	2001-03-13	National University Of Singapore	Small peptides having potent anti-angiogenic activity
AU2002257647A1 (en) *	2001-03-09	2002-09-24	Callistogen Ag	Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
FI110549B (fi)	2001-06-29	2003-02-14	Nokia Corp	Menetelmä ja järjestely liikkeen määrittämiseksi
US20030157101A1 (en)	2001-11-15	2003-08-21	Carlo Gambacorti-Passerini	Immunogenic ALK peptides
EP2189470A1 (en)	2001-12-10	2010-05-26	Green Peptide Co., Ltd.	Tumor antigens
CU23178A1 (es) *	2002-04-15	2006-09-22	Ct Ingenieria Genetica Biotech	INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA
JP2004018667A (ja)	2002-06-17	2004-01-22	National Institute Of Advanced Industrial & Technology	高分子化合物膜の表面における炭酸カルシウム被膜の製造方法
WO2004018667A1 (ja)	2002-08-26	2004-03-04	Kirin Beer Kabushiki Kaisha	ペプチド及びこれを含む医薬
EP1548032B9 (en)	2002-09-12	2009-10-28	Oncotherapy Science, Inc.	Kdr peptides and vaccines comprising the same
TW201109029A (en)	2009-06-11	2011-03-16	Oncotherapy Science Inc	Vaccine therapy for choroidal neovascularization

2006
- 2006-02-17 PT PT06714491T patent/PT1855707E/pt unknown
- 2006-02-17 SI SI200631350T patent/SI1855707T1/sl unknown
- 2006-02-17 EP EP10177960.1A patent/EP2289533B1/en active Active
- 2006-02-17 EP EP10177956A patent/EP2289532A1/en not_active Withdrawn
- 2006-02-17 DK DK09007549.0T patent/DK2095822T3/da active
- 2006-02-17 PT PT90075490T patent/PT2095822E/pt unknown
- 2006-02-17 PL PL06714491T patent/PL1855707T3/pl unknown
- 2006-02-17 EP EP06714491A patent/EP1855707B1/en not_active Not-in-force
- 2006-02-17 ES ES09007549.0T patent/ES2442294T3/es active Active
- 2006-02-17 DK DK10177960.1T patent/DK2289533T3/da active
- 2006-02-17 JP JP2007529685A patent/JP4931154B2/ja not_active Expired - Fee Related
- 2006-02-17 EP EP09007549.0A patent/EP2095822B1/en not_active Not-in-force
- 2006-02-17 SI SI200631689T patent/SI2095822T1/sl unknown
- 2006-02-17 PT PT101779601T patent/PT2289533E/pt unknown
- 2006-02-17 US US11/816,893 patent/US7919099B2/en active Active
- 2006-02-17 SI SI200631668T patent/SI2289533T1/sl unknown
- 2006-02-17 ES ES06714491T patent/ES2385396T3/es active Active
- 2006-02-17 PL PL10177960T patent/PL2289533T3/pl unknown
- 2006-02-17 ES ES10177960T patent/ES2435650T3/es active Active
- 2006-02-17 PL PL09007549T patent/PL2095822T3/pl unknown
- 2006-02-17 WO PCT/JP2006/303352 patent/WO2006093030A1/en not_active Ceased
- 2006-02-17 DK DK06714491.5T patent/DK1855707T3/da active
2010
- 2010-06-04 JP JP2010129158A patent/JP4843095B2/ja active Active
2011
- 2011-03-03 US US13/040,177 patent/US8257711B2/en not_active Expired - Fee Related
- 2011-12-05 JP JP2011265649A patent/JP5789820B2/ja not_active Expired - Fee Related
2012
- 2012-06-12 CY CY20121100533T patent/CY1112867T1/el unknown
- 2012-08-03 US US13/566,933 patent/US8663647B2/en not_active Expired - Fee Related
2014
- 2014-01-21 US US14/160,436 patent/US20140186381A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DK2095822T3 (da)	2014-01-13
EP2289532A1 (en)	2011-03-02
US8663647B2 (en)	2014-03-04
EP2289533B1 (en)	2013-09-18
ES2442294T3 (es)	2014-02-11
EP2289533A1 (en)	2011-03-02
PL1855707T3 (pl)	2012-08-31
US20090214581A1 (en)	2009-08-27
US20140186381A1 (en)	2014-07-03
PT2289533E (pt)	2013-12-10
US20110250219A1 (en)	2011-10-13
EP1855707A1 (en)	2007-11-21
US8257711B2 (en)	2012-09-04
DK1855707T3 (da)	2012-07-16
JP5789820B2 (ja)	2015-10-07
JP2010265269A (ja)	2010-11-25
PT2095822E (pt)	2013-12-09
PL2289533T3 (pl)	2014-02-28
SI2289533T1 (sl)	2013-11-29
SI2095822T1 (sl)	2013-12-31
PL2095822T3 (pl)	2014-03-31
EP2095822A1 (en)	2009-09-02
US7919099B2 (en)	2011-04-05
HK1133601A1 (en)	2010-04-01
HK1110529A1 (en)	2008-07-18
EP1855707B1 (en)	2012-04-04
HK1152873A1 (en)	2012-03-16
SI1855707T1 (sl)	2012-07-31
WO2006093030A1 (en)	2006-09-08
US20120294877A1 (en)	2012-11-22
ES2385396T3 (es)	2012-07-24
JP2012102105A (ja)	2012-05-31
EP2095822B1 (en)	2013-10-16
JP2008531463A (ja)	2008-08-14
JP4843095B2 (ja)	2011-12-21
PT1855707E (pt)	2012-05-25
JP4931154B2 (ja)	2012-05-16
CY1112867T1 (el)	2016-04-13
ES2435650T3 (es)	2013-12-20

Publication	Publication Date	Title
EP1548032A4 (en)	2006-03-01	KDR-PEPTIDES AND VACCINES CONTAINING THEM
PT2121731E (pt)	2013-10-24	Vacinas peptídicas para cancros que expressam antigénios associados a tumores
BR0010361A (pt)	2003-06-10	Seq ências genÈmicas de neisseria e uso destas
EP2476697A3 (en)	2013-11-27	Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
WO2006090810A3 (en)	2007-03-29	Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
CY1112867T1 (el)	2016-04-13	Πεπτιδια επιτοπων που προερχονται απο τον υποδοχεα 1 του αγγειακου ενδοθηλιακου αυξητικου παραγοντα και εμβολια περιεχοντας αυτα τα πεπτιδια
MX2009007261A (es)	2009-11-11	Vacuna de peptido foxp3.
MX2010005816A (es)	2010-08-04	Epítopos de péptido de stat3.
PT1962889E (pt)	2009-10-14	Polipéptido imunogénico formado por péptidos crípticos optimizados provenientes de antigénios tumorais, e suas utilizações
EP4047009A3 (en)	2022-11-16	Wdrpuh epitope peptides and vaccines containing the same
CY1114720T1 (el)	2016-10-05	Πεπτιδια επιτοπων που προερχονται απο τον υποδοχεα 1 του αγγειακου ενδοθηλιακου αυξητικου παραγοντα και εμβολια περιεχοντας αυτα τα πεπτιδια
WO2009149094A3 (en)	2010-03-04	Cytotoxic t cell defined egfr peptide and an optimized derivative peptide